                               SEQUENCE LISTING

<110> EIGER BIOPHARMACEUTICALS, INC.
 
<120> TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON 
      LAMBDA

<130> 097854-1152075-002410PC

<150> 62/721,763
<151> 2018-08-23

<150> 62/823,530
<151> 2019-03-25

<150> 62/831,548
<151> 2019-04-09

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 176
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Met Lys Pro Thr Thr Thr Gly Lys Gly Cys His Ile Gly Arg Phe Lys 
1               5                   10                  15      


Ser Leu Ser Pro Gln Glu Leu Ala Ser Phe Lys Lys Ala Arg Asp Ala 
            20                  25                  30          


Leu Glu Glu Ser Leu Lys Leu Lys Asn Trp Ser Cys Ser Ser Pro Val 
        35                  40                  45              


Phe Pro Gly Asn Trp Asp Leu Arg Leu Leu Gln Val Arg Glu Arg Pro 
    50                  55                  60                  


Val Ala Leu Glu Ala Glu Leu Ala Leu Thr Leu Lys Val Leu Glu Ala 
65                  70                  75                  80  


Ala Ala Gly Pro Ala Leu Glu Asp Val Leu Asp Gln Pro Leu His Thr 
                85                  90                  95      


Leu His His Ile Leu Ser Gln Leu Gln Ala Cys Ile Gln Pro Gln Pro 
            100                 105                 110         


Thr Ala Gly Pro Arg Pro Arg Gly Arg Leu His His Trp Leu His Arg 
        115                 120                 125             


Leu Gln Glu Ala Pro Lys Lys Glu Ser Ala Gly Cys Leu Glu Ala Ser 
    130                 135                 140                 


Val Thr Phe Asn Leu Phe Arg Leu Leu Thr Arg Asp Leu Lys Tyr Val 
145                 150                 155                 160 


Ala Asp Gly Asn Leu Ser Leu Arg Thr Ser Thr His Pro Glu Ser Thr 
                165                 170                 175     


